PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $84.16 million. The enterprise value is $35.16 million.
| Market Cap | 84.16M |
| Enterprise Value | 35.16M |
Important Dates
The last earnings date was Monday, February 10, 2025, after market close.
| Earnings Date | Feb 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 20.63 million shares outstanding. The number of shares has increased by 2.38% in one year.
| Current Share Class | 20.63M |
| Shares Outstanding | 20.63M |
| Shares Change (YoY) | +2.38% |
| Shares Change (QoQ) | -1.45% |
| Owned by Insiders (%) | 4.95% |
| Owned by Institutions (%) | 37.37% |
| Float | 16.66M |
Valuation Ratios
The trailing PE ratio is 239.10.
| PE Ratio | 239.10 |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| Forward PS | 0.35 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | 98.43 |
| P/OCF Ratio | 17.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.27, with an EV/FCF ratio of 41.13.
| EV / Earnings | 98.50 |
| EV / Sales | 0.14 |
| EV / EBITDA | 4.27 |
| EV / EBIT | 14.86 |
| EV / FCF | 41.13 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.43 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 1.29 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.36% and return on invested capital (ROIC) is 1.49%.
| Return on Equity (ROE) | 0.36% |
| Return on Assets (ROA) | 0.93% |
| Return on Invested Capital (ROIC) | 1.49% |
| Return on Capital Employed (ROCE) | 2.44% |
| Revenue Per Employee | $860,662 |
| Profits Per Employee | $1,244 |
| Employee Count | 287 |
| Asset Turnover | 1.55 |
| Inventory Turnover | 7.70 |
Taxes
In the past 12 months, PetMed Express has paid $1.56 million in taxes.
| Income Tax | 1.56M |
| Effective Tax Rate | 81.36% |
Stock Price Statistics
The stock price has decreased by -18.73% in the last 52 weeks. The beta is 0.79, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -18.73% |
| 50-Day Moving Average | 4.73 |
| 200-Day Moving Average | 4.26 |
| Relative Strength Index (RSI) | 40.15 |
| Average Volume (20 Days) | 345,558 |
Short Selling Information
The latest short interest is 1.50 million, so 7.27% of the outstanding shares have been sold short.
| Short Interest | 1.50M |
| Short Previous Month | 1.29M |
| Short % of Shares Out | 7.27% |
| Short % of Float | 9.01% |
| Short Ratio (days to cover) | 4.81 |
Income Statement
In the last 12 months, PetMed Express had revenue of $247.01 million and earned $357,000 in profits. Earnings per share was $0.02.
| Revenue | 247.01M |
| Gross Profit | 68.37M |
| Operating Income | 2.37M |
| Pretax Income | -133,000 |
| Net Income | 357,000 |
| EBITDA | 8.23M |
| EBIT | 2.37M |
| Earnings Per Share (EPS) | $0.02 |
Balance Sheet
The company has $50.10 million in cash and $1.11 million in debt, giving a net cash position of $49.00 million or $2.38 per share.
| Cash & Cash Equivalents | 50.10M |
| Total Debt | 1.11M |
| Net Cash | 49.00M |
| Net Cash Per Share | $2.38 |
| Equity (Book Value) | 96.18M |
| Book Value Per Share | 4.66 |
| Working Capital | 20.42M |
Cash Flow
In the last 12 months, operating cash flow was $4.83 million and capital expenditures -$3.98 million, giving a free cash flow of $855,000.
| Operating Cash Flow | 4.83M |
| Capital Expenditures | -3.98M |
| Free Cash Flow | 855,000 |
| FCF Per Share | $0.04 |
Margins
Gross margin is 27.68%, with operating and profit margins of 0.96% and 0.14%.
| Gross Margin | 27.68% |
| Operating Margin | 0.96% |
| Pretax Margin | 0.78% |
| Profit Margin | 0.14% |
| EBITDA Margin | 3.33% |
| EBIT Margin | 0.96% |
| FCF Margin | 0.35% |
Dividends & Yields
PetMed Express does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.38% |
| Shareholder Yield | -2.38% |
| Earnings Yield | 0.42% |
| FCF Yield | 1.02% |
Analyst Forecast
The average price target for PetMed Express is $3.50, which is -14.22% lower than the current price. The consensus rating is "Sell".
| Price Target | $3.50 |
| Price Target Difference | -14.22% |
| Analyst Consensus | Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 3.84 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.84 |
| Piotroski F-Score | 5 |